Novartis recently inked an exclusive worldwide license and collaboration agreement with regenerative therapy venture Mesoblast to develop, commercialize and manufacture remestemcel-L for the treatment of…
South Korean-based Enzychem Lifesciences (KOSDAQ: 183490) just announced that the US Food and Drug Administration (FDA) has accepted its Investigational New Drug Application (IND) to…
University of California Irvine, (UCI) recently announced their participation in a COVID-19-focused clinical trial investigating a drug called Aviptadil in at risk patients. Dr. Richard Lee,…
Mount Sinai Health System will be conducting a study using remestemcel-L (Ryoncil), an innovative allogeneic stem cell therapy in patients with coronavirus disease 2019 (COVID-19). Mount…
Wales doesn’t necessarily make international news often, despite its cultural richness, serene beauty and legacy of intelligent inventors. But it has now with another invention—the…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
